| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 58.31B | 58.71B | 54.61B | 56.05B | 78.58B | 46.06B |
| Gross Profit | 17.02B | 14.46B | 16.03B | 17.81B | 29.63B | 14.73B |
| EBITDA | 22.44B | 23.18B | 24.43B | 25.78B | 37.13B | 21.09B |
| Net Income | 7.32B | 7.99B | 9.22B | 10.92B | 18.62B | 8.08B |
Balance Sheet | ||||||
| Total Assets | 122.72B | 121.94B | 122.78B | 95.92B | 93.83B | 90.66B |
| Cash, Cash Equivalents and Short-Term Investments | 6.36B | 6.98B | 6.11B | 6.61B | 9.24B | 6.59B |
| Total Debt | 23.33B | 23.44B | 25.35B | 19.63B | 17.19B | 19.93B |
| Total Liabilities | 58.18B | 57.45B | 57.98B | 46.65B | 45.83B | 45.26B |
| Stockholders Equity | 64.54B | 64.49B | 64.80B | 49.28B | 48.00B | 45.41B |
Cash Flow | ||||||
| Free Cash Flow | 18.33B | 16.77B | 8.01B | 8.72B | 18.16B | 11.67B |
| Operating Cash Flow | 17.98B | 19.80B | 20.12B | 19.96B | 28.31B | 17.00B |
| Investing Cash Flow | -9.30B | -8.84B | -11.15B | -12.00B | -8.74B | -8.54B |
| Financing Cash Flow | -9.15B | -10.10B | -8.84B | -8.66B | -18.05B | -6.33B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $74.71B | 9.71 | 18.28% | 3.79% | 0.31% | -5.71% | |
69 Neutral | $149.13B | 18.50 | 11.29% | 3.43% | 1.02% | -25.38% | |
69 Neutral | $57.06B | 65.10 | 14.78% | 2.64% | 1.96% | -18.06% | |
69 Neutral | $59.30B | 4.74 | 12.82% | 2.39% | -15.17% | -66.00% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
64 Neutral | $380.59B | 46.35 | 6.23% | 4.54% | -2.16% | -33.98% | |
62 Neutral | $57.26B | 97.11 | 1.06% | 2.70% | 18.09% | -94.57% |